nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.61	1	CbGbCtD
Dolutegravir—POU2F2—lymphoid tissue—acquired immunodeficiency syndrome	0.0088	0.19	CbGeAlD
Dolutegravir—POU2F2—blood—acquired immunodeficiency syndrome	0.00828	0.179	CbGeAlD
Dolutegravir—POU2F2—lung—acquired immunodeficiency syndrome	0.00726	0.156	CbGeAlD
Dolutegravir—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00682	0.147	CbGeAlD
Dolutegravir—POU2F2—brain—acquired immunodeficiency syndrome	0.00514	0.111	CbGeAlD
Dolutegravir—POU2F2—lymph node—acquired immunodeficiency syndrome	0.00497	0.107	CbGeAlD
Dolutegravir—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.00262	0.0565	CbGeAlD
Dolutegravir—UGT1A1—blood—acquired immunodeficiency syndrome	0.0025	0.0539	CbGeAlD
Dolutegravir—Flatulence—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.00126	CcSEcCtD
Dolutegravir—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000432	0.00126	CcSEcCtD
Dolutegravir—Renal failure—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.00125	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00043	0.00125	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000428	0.00125	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000427	0.00124	CcSEcCtD
Dolutegravir—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.00124	CcSEcCtD
Dolutegravir—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00124	CcSEcCtD
Dolutegravir—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000425	0.00124	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000422	0.00123	CcSEcCtD
Dolutegravir—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.000422	0.00123	CcSEcCtD
Dolutegravir—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00042	0.00122	CcSEcCtD
Dolutegravir—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000416	0.00121	CcSEcCtD
Dolutegravir—Renal failure—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00121	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.00121	CcSEcCtD
Dolutegravir—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000413	0.0012	CcSEcCtD
Dolutegravir—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00118	CcSEcCtD
Dolutegravir—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000405	0.00118	CcSEcCtD
Dolutegravir—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.000403	0.00117	CcSEcCtD
Dolutegravir—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000403	0.00117	CcSEcCtD
Dolutegravir—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000402	0.00117	CcSEcCtD
Dolutegravir—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000401	0.00117	CcSEcCtD
Dolutegravir—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000399	0.00116	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000399	0.00116	CcSEcCtD
Dolutegravir—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000396	0.00115	CcSEcCtD
Dolutegravir—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000396	0.00115	CcSEcCtD
Dolutegravir—Renal failure—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00115	CcSEcCtD
Dolutegravir—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00114	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000389	0.00113	CcSEcCtD
Dolutegravir—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000388	0.00113	CcSEcCtD
Dolutegravir—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000385	0.00112	CcSEcCtD
Dolutegravir—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.000381	0.00111	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00111	CcSEcCtD
Dolutegravir—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.0011	CcSEcCtD
Dolutegravir—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000376	0.0011	CcSEcCtD
Dolutegravir—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000375	0.00109	CcSEcCtD
Dolutegravir—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000375	0.00109	CcSEcCtD
Dolutegravir—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000374	0.00109	CcSEcCtD
Dolutegravir—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000374	0.00109	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00108	CcSEcCtD
Dolutegravir—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000371	0.00108	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00037	0.00108	CcSEcCtD
Dolutegravir—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00037	0.00108	CcSEcCtD
Dolutegravir—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00107	CcSEcCtD
Dolutegravir—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000368	0.00107	CcSEcCtD
Dolutegravir—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000368	0.00107	CcSEcCtD
Dolutegravir—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.00106	CcSEcCtD
Dolutegravir—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00105	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.00104	CcSEcCtD
Dolutegravir—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000357	0.00104	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00104	CcSEcCtD
Dolutegravir—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000356	0.00104	CcSEcCtD
Dolutegravir—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00103	CcSEcCtD
Dolutegravir—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000352	0.00103	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000352	0.00102	CcSEcCtD
Dolutegravir—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00102	CcSEcCtD
Dolutegravir—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000351	0.00102	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00035	0.00102	CcSEcCtD
Dolutegravir—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000349	0.00102	CcSEcCtD
Dolutegravir—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00101	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00101	CcSEcCtD
Dolutegravir—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000344	0.001	CcSEcCtD
Dolutegravir—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000342	0.000995	CcSEcCtD
Dolutegravir—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000342	0.000994	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000339	0.000987	CcSEcCtD
Dolutegravir—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000338	0.000985	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000338	0.000984	CcSEcCtD
Dolutegravir—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.000982	CcSEcCtD
Dolutegravir—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000337	0.000981	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000333	0.000969	CcSEcCtD
Dolutegravir—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.000968	CcSEcCtD
Dolutegravir—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000332	0.000967	CcSEcCtD
Dolutegravir—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.000965	CcSEcCtD
Dolutegravir—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000329	0.000959	CcSEcCtD
Dolutegravir—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000329	0.000958	CcSEcCtD
Dolutegravir—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000328	0.000954	CcSEcCtD
Dolutegravir—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000328	0.000954	CcSEcCtD
Dolutegravir—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000327	0.000953	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.000952	CcSEcCtD
Dolutegravir—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000327	0.000951	CcSEcCtD
Dolutegravir—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.000949	CcSEcCtD
Dolutegravir—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000326	0.000948	CcSEcCtD
Dolutegravir—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000325	0.000946	CcSEcCtD
Dolutegravir—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.000945	CcSEcCtD
Dolutegravir—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000325	0.000945	CcSEcCtD
Dolutegravir—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000322	0.000937	CcSEcCtD
Dolutegravir—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.000918	CcSEcCtD
Dolutegravir—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00031	0.000903	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.000903	CcSEcCtD
Dolutegravir—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.000902	CcSEcCtD
Dolutegravir—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.000901	CcSEcCtD
Dolutegravir—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00031	0.000901	CcSEcCtD
Dolutegravir—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.000895	CcSEcCtD
Dolutegravir—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000307	0.000894	CcSEcCtD
Dolutegravir—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000307	0.000893	CcSEcCtD
Dolutegravir—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000306	0.000889	CcSEcCtD
Dolutegravir—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000305	0.000887	CcSEcCtD
Dolutegravir—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000303	0.000882	CcSEcCtD
Dolutegravir—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000303	0.000881	CcSEcCtD
Dolutegravir—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000302	0.00088	CcSEcCtD
Dolutegravir—Rash—Didanosine—acquired immunodeficiency syndrome	0.0003	0.000874	CcSEcCtD
Dolutegravir—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0003	0.000873	CcSEcCtD
Dolutegravir—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0003	0.000873	CcSEcCtD
Dolutegravir—Headache—Didanosine—acquired immunodeficiency syndrome	0.000298	0.000868	CcSEcCtD
Dolutegravir—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000298	0.000866	CcSEcCtD
Dolutegravir—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000297	0.000863	CcSEcCtD
Dolutegravir—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.000862	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000294	0.000855	CcSEcCtD
Dolutegravir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.000854	CcSEcCtD
Dolutegravir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000293	0.000854	CcSEcCtD
Dolutegravir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000293	0.000853	CcSEcCtD
Dolutegravir—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000292	0.000851	CcSEcCtD
Dolutegravir—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000292	0.000851	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.000842	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00084	CcSEcCtD
Dolutegravir—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000288	0.000839	CcSEcCtD
Dolutegravir—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000288	0.000839	CcSEcCtD
Dolutegravir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.000831	CcSEcCtD
Dolutegravir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000284	0.000827	CcSEcCtD
Dolutegravir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.000826	CcSEcCtD
Dolutegravir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000283	0.000823	CcSEcCtD
Dolutegravir—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000283	0.000823	CcSEcCtD
Dolutegravir—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.000822	CcSEcCtD
Dolutegravir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000279	0.000811	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.000811	CcSEcCtD
Dolutegravir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000274	0.000798	CcSEcCtD
Dolutegravir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.000797	CcSEcCtD
Dolutegravir—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000273	0.000796	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000795	CcSEcCtD
Dolutegravir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.000795	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.000793	CcSEcCtD
Dolutegravir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000272	0.000792	CcSEcCtD
Dolutegravir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.000792	CcSEcCtD
Dolutegravir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00079	CcSEcCtD
Dolutegravir—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.000786	CcSEcCtD
Dolutegravir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.000785	CcSEcCtD
Dolutegravir—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000269	0.000784	CcSEcCtD
Dolutegravir—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000268	0.000781	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000774	CcSEcCtD
Dolutegravir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000264	0.000769	CcSEcCtD
Dolutegravir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.000768	CcSEcCtD
Dolutegravir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000264	0.000767	CcSEcCtD
Dolutegravir—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000263	0.000765	CcSEcCtD
Dolutegravir—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000261	0.000761	CcSEcCtD
Dolutegravir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000261	0.00076	CcSEcCtD
Dolutegravir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00076	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.000759	CcSEcCtD
Dolutegravir—Rash—Stavudine—acquired immunodeficiency syndrome	0.000261	0.000759	CcSEcCtD
Dolutegravir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.000758	CcSEcCtD
Dolutegravir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00026	0.000758	CcSEcCtD
Dolutegravir—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00026	0.000756	CcSEcCtD
Dolutegravir—Headache—Stavudine—acquired immunodeficiency syndrome	0.000259	0.000754	CcSEcCtD
Dolutegravir—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000259	0.000754	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000752	CcSEcCtD
Dolutegravir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00075	CcSEcCtD
Dolutegravir—Rash—Abacavir—acquired immunodeficiency syndrome	0.000257	0.000747	CcSEcCtD
Dolutegravir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000257	0.000747	CcSEcCtD
Dolutegravir—Headache—Abacavir—acquired immunodeficiency syndrome	0.000255	0.000743	CcSEcCtD
Dolutegravir—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000254	0.00074	CcSEcCtD
Dolutegravir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00074	CcSEcCtD
Dolutegravir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.000735	CcSEcCtD
Dolutegravir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.000732	CcSEcCtD
Dolutegravir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.000727	CcSEcCtD
Dolutegravir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.000725	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000719	CcSEcCtD
Dolutegravir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.000717	CcSEcCtD
Dolutegravir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000246	0.000717	CcSEcCtD
Dolutegravir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.000716	CcSEcCtD
Dolutegravir—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000246	0.000715	CcSEcCtD
Dolutegravir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000708	CcSEcCtD
Dolutegravir—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000242	0.000704	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000702	CcSEcCtD
Dolutegravir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000701	CcSEcCtD
Dolutegravir—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00024	0.000698	CcSEcCtD
Dolutegravir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.000695	CcSEcCtD
Dolutegravir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.000692	CcSEcCtD
Dolutegravir—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000236	0.000688	CcSEcCtD
Dolutegravir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000677	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000676	CcSEcCtD
Dolutegravir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000675	CcSEcCtD
Dolutegravir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000675	CcSEcCtD
Dolutegravir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000666	CcSEcCtD
Dolutegravir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.000665	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000665	CcSEcCtD
Dolutegravir—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000659	CcSEcCtD
Dolutegravir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000659	CcSEcCtD
Dolutegravir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.000659	CcSEcCtD
Dolutegravir—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.000655	CcSEcCtD
Dolutegravir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00065	CcSEcCtD
Dolutegravir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000648	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000645	CcSEcCtD
Dolutegravir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000644	CcSEcCtD
Dolutegravir—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000221	0.000643	CcSEcCtD
Dolutegravir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.000643	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00064	CcSEcCtD
Dolutegravir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000631	CcSEcCtD
Dolutegravir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.000629	CcSEcCtD
Dolutegravir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000622	CcSEcCtD
Dolutegravir—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.000621	CcSEcCtD
Dolutegravir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000619	CcSEcCtD
Dolutegravir—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000618	CcSEcCtD
Dolutegravir—Rash—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000613	CcSEcCtD
Dolutegravir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000613	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000611	CcSEcCtD
Dolutegravir—Headache—Indinavir—acquired immunodeficiency syndrome	0.000209	0.000609	CcSEcCtD
Dolutegravir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.000608	CcSEcCtD
Dolutegravir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000602	CcSEcCtD
Dolutegravir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000599	CcSEcCtD
Dolutegravir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00059	CcSEcCtD
Dolutegravir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000584	CcSEcCtD
Dolutegravir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000583	CcSEcCtD
Dolutegravir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000581	CcSEcCtD
Dolutegravir—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000579	CcSEcCtD
Dolutegravir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000579	CcSEcCtD
Dolutegravir—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000578	CcSEcCtD
Dolutegravir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000577	CcSEcCtD
Dolutegravir—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000576	CcSEcCtD
Dolutegravir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000575	CcSEcCtD
Dolutegravir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000562	CcSEcCtD
Dolutegravir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000559	CcSEcCtD
Dolutegravir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000556	CcSEcCtD
Dolutegravir—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000554	CcSEcCtD
Dolutegravir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000554	CcSEcCtD
Dolutegravir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000554	CcSEcCtD
Dolutegravir—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000551	CcSEcCtD
Dolutegravir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00055	CcSEcCtD
Dolutegravir—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000546	CcSEcCtD
Dolutegravir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000538	CcSEcCtD
Dolutegravir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000536	CcSEcCtD
Dolutegravir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000536	CcSEcCtD
Dolutegravir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000528	CcSEcCtD
Dolutegravir—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000522	CcSEcCtD
Dolutegravir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000518	CcSEcCtD
Dolutegravir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000517	CcSEcCtD
Dolutegravir—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000513	CcSEcCtD
Dolutegravir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000512	CcSEcCtD
Dolutegravir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000511	CcSEcCtD
Dolutegravir—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000509	CcSEcCtD
Dolutegravir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000498	CcSEcCtD
Dolutegravir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000494	CcSEcCtD
Dolutegravir—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000493	CcSEcCtD
Dolutegravir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000493	CcSEcCtD
Dolutegravir—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00049	CcSEcCtD
Dolutegravir—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000483	CcSEcCtD
Dolutegravir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000475	CcSEcCtD
Dolutegravir—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000471	CcSEcCtD
Dolutegravir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.00047	CcSEcCtD
Dolutegravir—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000468	CcSEcCtD
Dolutegravir—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000465	CcSEcCtD
Dolutegravir—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000444	CcSEcCtD
